Global Imbruvica Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 103 pages | ID: G6258BF7367GEN
GlobalInfoResearch

Abstracts

Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstr?m's macroglobulinemia.

SCOPE OF THE REPORT:

The global Imbruvica market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Imbruvica.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Imbruvica market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Imbruvica market by product type and applications/end industries.

Market Segment by Companies, this report covers

• AbbVie (Pharmacyclics)
• Johnson & Johnson (Janssen Biotech)
• SP Laboratories

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• 5 mg
• 10 mg
• 140 mg

Market Segment by Applications, can be divided into

• Mantle Cell Lymphoma
• Chronic Lymphocytic Leukemia
• Waldenstr?m's Macroglobulinemia
• Relapsed/Refractory Marginal Zone Lymphoma
• Chronic Graft-Versus-Host-Disease

Contents

1 IMBRUVICA MARKET OVERVIEW

1.1 Product Overview and Scope of Imbruvica
1.2 Classification of Imbruvica by Types
  1.2.1 Global Imbruvica Revenue Comparison by Types (2017-2023)
  1.2.2 Global Imbruvica Revenue Market Share by Types in 2017
  1.2.3 5 mg
  1.2.4 10 mg
  1.2.5 140 mg
1.3 Global Imbruvica Market by Application
  1.3.1 Global Imbruvica Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Mantle Cell Lymphoma
  1.3.3 Chronic Lymphocytic Leukemia
  1.3.4 Waldenstr?m's Macroglobulinemia
  1.3.5 Relapsed/Refractory Marginal Zone Lymphoma
  1.3.6 Chronic Graft-Versus-Host-Disease
1.4 Global Imbruvica Market by Regions
  1.4.1 Global Imbruvica Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Imbruvica Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Imbruvica Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Imbruvica Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Imbruvica Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Imbruvica Status and Prospect (2013-2023)
1.5 Global Market Size of Imbruvica (2013-2023)

2 MANUFACTURERS PROFILES

2.1 AbbVie (Pharmacyclics)
  2.1.1 Business Overview
  2.1.2 Imbruvica Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AbbVie (Pharmacyclics) Imbruvica Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson (Janssen Biotech)
  2.2.1 Business Overview
  2.2.2 Imbruvica Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Revenue, Gross Margin and Market Share (2016-2017)
2.3 SP Laboratories
  2.3.1 Business Overview
  2.3.2 Imbruvica Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 SP Laboratories Imbruvica Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL IMBRUVICA MARKET COMPETITION, BY PLAYERS

3.1 Global Imbruvica Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Imbruvica Players Market Share
  3.2.2 Top 10 Imbruvica Players Market Share
3.3 Market Competition Trend

4 GLOBAL IMBRUVICA MARKET SIZE BY REGIONS

4.1 Global Imbruvica Revenue and Market Share by Regions
4.2 North America Imbruvica Revenue and Growth Rate (2013-2018)
4.3 Europe Imbruvica Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Imbruvica Revenue and Growth Rate (2013-2018)
4.5 South America Imbruvica Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Imbruvica Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA IMBRUVICA REVENUE BY COUNTRIES

5.1 North America Imbruvica Revenue by Countries (2013-2018)
5.2 USA Imbruvica Revenue and Growth Rate (2013-2018)
5.3 Canada Imbruvica Revenue and Growth Rate (2013-2018)
5.4 Mexico Imbruvica Revenue and Growth Rate (2013-2018)

6 EUROPE IMBRUVICA REVENUE BY COUNTRIES

6.1 Europe Imbruvica Revenue by Countries (2013-2018)
6.2 Germany Imbruvica Revenue and Growth Rate (2013-2018)
6.3 UK Imbruvica Revenue and Growth Rate (2013-2018)
6.4 France Imbruvica Revenue and Growth Rate (2013-2018)
6.5 Russia Imbruvica Revenue and Growth Rate (2013-2018)
6.6 Italy Imbruvica Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC IMBRUVICA REVENUE BY COUNTRIES

7.1 Asia-Pacific Imbruvica Revenue by Countries (2013-2018)
7.2 China Imbruvica Revenue and Growth Rate (2013-2018)
7.3 Japan Imbruvica Revenue and Growth Rate (2013-2018)
7.4 Korea Imbruvica Revenue and Growth Rate (2013-2018)
7.5 India Imbruvica Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Imbruvica Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA IMBRUVICA REVENUE BY COUNTRIES

8.1 South America Imbruvica Revenue by Countries (2013-2018)
8.2 Brazil Imbruvica Revenue and Growth Rate (2013-2018)
8.3 Argentina Imbruvica Revenue and Growth Rate (2013-2018)
8.4 Colombia Imbruvica Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE IMBRUVICA BY COUNTRIES

9.1 Middle East and Africa Imbruvica Revenue by Countries (2013-2018)
9.2 Saudi Arabia Imbruvica Revenue and Growth Rate (2013-2018)
9.3 UAE Imbruvica Revenue and Growth Rate (2013-2018)
9.4 Egypt Imbruvica Revenue and Growth Rate (2013-2018)
9.5 Nigeria Imbruvica Revenue and Growth Rate (2013-2018)
9.6 South Africa Imbruvica Revenue and Growth Rate (2013-2018)

10 GLOBAL IMBRUVICA MARKET SEGMENT BY TYPE

10.1 Global Imbruvica Revenue and Market Share by Type (2013-2018)
10.2 Global Imbruvica Market Forecast by Type (2018-2023)
10.3 5 mg Revenue Growth Rate (2013-2023)
10.4 10 mg Revenue Growth Rate (2013-2023)
10.5 140 mg Revenue Growth Rate (2013-2023)

11 GLOBAL IMBRUVICA MARKET SEGMENT BY APPLICATION

11.1 Global Imbruvica Revenue Market Share by Application (2013-2018)
11.2 Imbruvica Market Forecast by Application (2018-2023)
11.3 Mantle Cell Lymphoma Revenue Growth (2013-2018)
11.4 Chronic Lymphocytic Leukemia Revenue Growth (2013-2018)
11.5 Waldenstr?m's Macroglobulinemia Revenue Growth (2013-2018)
11.6 Relapsed/Refractory Marginal Zone Lymphoma Revenue Growth (2013-2018)
11.7 Chronic Graft-Versus-Host-Disease Revenue Growth (2013-2018)

12 GLOBAL IMBRUVICA MARKET SIZE FORECAST (2018-2023)

12.1 Global Imbruvica Market Size Forecast (2018-2023)
12.2 Global Imbruvica Market Forecast by Regions (2018-2023)
12.3 North America Imbruvica Revenue Market Forecast (2018-2023)
12.4 Europe Imbruvica Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Imbruvica Revenue Market Forecast (2018-2023)
12.6 South America Imbruvica Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Imbruvica Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Imbruvica Picture
Table Product Specifications of Imbruvica
Table Global Imbruvica and Revenue (Million USD) Market Split by Product Type
Figure Global Imbruvica Revenue Market Share by Types in 2017
Figure 5 mg Picture
Figure 10 mg Picture
Figure 140 mg Picture
Table Global Imbruvica Revenue (Million USD) by Application (2013-2023)
Figure Imbruvica Revenue Market Share by Applications in 2017
Figure Mantle Cell Lymphoma Picture
Figure Chronic Lymphocytic Leukemia Picture
Figure Waldenstr?m's Macroglobulinemia Picture
Figure Relapsed/Refractory Marginal Zone Lymphoma Picture
Figure Chronic Graft-Versus-Host-Disease Picture
Table Global Market Imbruvica Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Imbruvica Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Imbruvica Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Imbruvica Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Imbruvica Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Imbruvica Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Imbruvica Revenue (Million USD) and Growth Rate (2013-2023)
Table AbbVie (Pharmacyclics) Basic Information, Manufacturing Base and Competitors
Table AbbVie (Pharmacyclics) Imbruvica Type and Applications
Table AbbVie (Pharmacyclics) Imbruvica Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson (Janssen Biotech) Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson (Janssen Biotech) Imbruvica Type and Applications
Table Johnson & Johnson (Janssen Biotech) Imbruvica Revenue, Gross Margin and Market Share (2016-2017)
Table SP Laboratories Basic Information, Manufacturing Base and Competitors
Table SP Laboratories Imbruvica Type and Applications
Table SP Laboratories Imbruvica Revenue, Gross Margin and Market Share (2016-2017)
Table Global Imbruvica Revenue (Million USD) by Players (2013-2018)
Table Global Imbruvica Revenue Share by Players (2013-2018)
Figure Global Imbruvica Revenue Share by Players in 2016
Figure Global Imbruvica Revenue Share by Players in 2017
Figure Global Top 5 Players Imbruvica Revenue Market Share in 2017
Figure Global Top 10 Players Imbruvica Revenue Market Share in 2017
Figure Global Imbruvica Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Imbruvica Revenue (Million USD) by Regions (2013-2018)
Table Global Imbruvica Revenue Market Share by Regions (2013-2018)
Figure Global Imbruvica Revenue Market Share by Regions (2013-2018)
Figure Global Imbruvica Revenue Market Share by Regions in 2017
Figure North America Imbruvica Revenue and Growth Rate (2013-2018)
Figure Europe Imbruvica Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Imbruvica Revenue and Growth Rate (2013-2018)
Figure South America Imbruvica Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Imbruvica Revenue and Growth Rate (2013-2018)
Table North America Imbruvica Revenue by Countries (2013-2018)
Table North America Imbruvica Revenue Market Share by Countries (2013-2018)
Figure North America Imbruvica Revenue Market Share by Countries (2013-2018)
Figure North America Imbruvica Revenue Market Share by Countries in 2017
Figure USA Imbruvica Revenue and Growth Rate (2013-2018)
Figure Canada Imbruvica Revenue and Growth Rate (2013-2018)
Figure Mexico Imbruvica Revenue and Growth Rate (2013-2018)
Table Europe Imbruvica Revenue (Million USD) by Countries (2013-2018)
Figure Europe Imbruvica Revenue Market Share by Countries (2013-2018)
Figure Europe Imbruvica Revenue Market Share by Countries in 2017
Figure Germany Imbruvica Revenue and Growth Rate (2013-2018)
Figure UK Imbruvica Revenue and Growth Rate (2013-2018)
Figure France Imbruvica Revenue and Growth Rate (2013-2018)
Figure Russia Imbruvica Revenue and Growth Rate (2013-2018)
Figure Italy Imbruvica Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Imbruvica Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Imbruvica Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Imbruvica Revenue Market Share by Countries in 2017
Figure China Imbruvica Revenue and Growth Rate (2013-2018)
Figure Japan Imbruvica Revenue and Growth Rate (2013-2018)
Figure Korea Imbruvica Revenue and Growth Rate (2013-2018)
Figure India Imbruvica Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Imbruvica Revenue and Growth Rate (2013-2018)
Table South America Imbruvica Revenue by Countries (2013-2018)
Table South America Imbruvica Revenue Market Share by Countries (2013-2018)
Figure South America Imbruvica Revenue Market Share by Countries (2013-2018)
Figure South America Imbruvica Revenue Market Share by Countries in 2017
Figure Brazil Imbruvica Revenue and Growth Rate (2013-2018)
Figure Argentina Imbruvica Revenue and Growth Rate (2013-2018)
Figure Colombia Imbruvica Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Imbruvica Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Imbruvica Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Imbruvica Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Imbruvica Revenue Market Share by Countries in 2017
Figure Saudi Arabia Imbruvica Revenue and Growth Rate (2013-2018)
Figure UAE Imbruvica Revenue and Growth Rate (2013-2018)
Figure Egypt Imbruvica Revenue and Growth Rate (2013-2018)
Figure Nigeria Imbruvica Revenue and Growth Rate (2013-2018)
Figure South Africa Imbruvica Revenue and Growth Rate (2013-2018)
Table Global Imbruvica Revenue (Million USD) by Type (2013-2018)
Table Global Imbruvica Revenue Share by Type (2013-2018)
Figure Global Imbruvica Revenue Share by Type (2013-2018)
Figure Global Imbruvica Revenue Share by Type in 2017
Table Global Imbruvica Revenue Forecast by Type (2018-2023)
Figure Global Imbruvica Market Share Forecast by Type (2018-2023)
Figure Global 5 mg Revenue Growth Rate (2013-2018)
Figure Global 10 mg Revenue Growth Rate (2013-2018)
Figure Global 140 mg Revenue Growth Rate (2013-2018)
Table Global Imbruvica Revenue by Application (2013-2018)
Table Global Imbruvica Revenue Share by Application (2013-2018)
Figure Global Imbruvica Revenue Share by Application (2013-2018)
Figure Global Imbruvica Revenue Share by Application in 2017
Table Global Imbruvica Revenue Forecast by Application (2018-2023)
Figure Global Imbruvica Market Share Forecast by Application (2018-2023)
Figure Global Mantle Cell Lymphoma Revenue Growth Rate (2013-2018)
Figure Global Chronic Lymphocytic Leukemia Revenue Growth Rate (2013-2018)
Figure Global Waldenstr?m's Macroglobulinemia Revenue Growth Rate (2013-2018)
Figure Global Relapsed/Refractory Marginal Zone Lymphoma Revenue Growth Rate (2013-2018)
Figure Global Chronic Graft-Versus-Host-Disease Revenue Growth Rate (2013-2018)
Figure Global Imbruvica Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Imbruvica Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Imbruvica Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Imbruvica Revenue Market Forecast (2018-2023)
Figure Europe Imbruvica Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Imbruvica Revenue Market Forecast (2018-2023)
Figure South America Imbruvica Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Imbruvica Revenue Market Forecast (2018-2023)